<DOC>
	<DOCNO>NCT00292227</DOCNO>
	<brief_summary>The purpose trial ass whether rotigotine effect electrical activity heart . Moxifloxacin infusion use positive control ass assay sensitivity .</brief_summary>
	<brief_title>Cardiac Effects Rotigotine Transdermal System Subjects With Advanced-stage Idiopathic Parkinson 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>N 0437</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>Male female least 18 year age Advancedstage idiopathic Parkinson 's disease require treatment levodopa . Nonchildbearing potential Atypical Parkinson 's syndrome ( ) . History pallidotomy , thalamotomy , deep brain stimulation , fetal tissue transplant . Significant tremor dyskinesia . Severe dysfunction autonomic nervous system . History transient ischemic attack stroke within last 12 month . Conduction abnormality relevant cardiac dysfunction and/or myocardial infarction within last 12 month . History current condition additional risk factor Torsade de Pointes ( eg , heart failure , hypokalemia ) , family history long QT syndrome and/or Torsade de Pointes . No stable sinus rhythm : 20 ectopics/h . Any clinically relevant ECG abnormality . History current condition epilepsy and/or seizure . History current condition atopic eczematous dermatitis , psoriasis , another active skin disease . History current condition symptomatic orthostatic hypotension . History current condition significant skin hypersensitivity adhesives transdermal product recent unresolved contact dermatitis . History glucose 6phosphate dehydrogenase deficiency . History tendonitis tendon rupture quinolone antibiotic . Renal hepatic dysfunction . Treatment dopamine agonist , MAO A inhibitor , reserpine , alphamethyldopa Therapy know produce nontrivial prolongation QT interval .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>advanced-stage idiopathic Parkinson 's disease</keyword>
</DOC>